2-Deoxy-D-glucose
Overview of 2-Deoxy-D-glucose

2-Deoxy-D-glucose (2-DG) is a glucose molecule that has been modified by the removal of an oxygen atom from the second carbon. This alteration prevents it from undergoing further glycolysis, making it a useful tool in biochemical research and a potential therapeutic agent.
Chemical Properties[edit]
2-Deoxy-D-glucose is a glucose analog that differs from normal glucose by the absence of a hydroxyl group at the C-2 position. This structural change is crucial as it inhibits the molecule's ability to proceed through the glycolytic pathway.
Mechanism of Action[edit]
2-DG is taken up by cells via the same transporters as glucose. Once inside the cell, it is phosphorylated by hexokinase to form 2-deoxy-D-glucose-6-phosphate. However, this compound cannot be further metabolized by phosphoglucose isomerase, leading to an accumulation of 2-DG-6-phosphate and a subsequent decrease in glycolysis and ATP production.
Applications in Research[edit]
2-Deoxy-D-glucose is widely used in metabolic studies to investigate the role of glycolysis in various cellular processes. It is also employed in cancer research to study the Warburg effect, where cancer cells preferentially utilize glycolysis for energy production even in the presence of oxygen.
Therapeutic Potential[edit]
The ability of 2-DG to inhibit glycolysis has led to its investigation as a potential anticancer agent. By targeting the altered metabolic pathways in cancer cells, 2-DG may selectively inhibit tumor growth while sparing normal cells.
Safety and Side Effects[edit]
While 2-DG shows promise in preclinical studies, its use in humans is associated with potential side effects such as hypoglycemia and gastrointestinal discomfort. Further research is needed to fully understand its safety profile and therapeutic window.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian